TIVERTON, ON – September 4, 2019 – Bruce Power, Nordion, and Xcision have entered into a collaborative framework agreement to support the use of Cobalt-60 and the GammaPod™ for life-saving cancer treatments.Collaborative Framework Agreement • November 4th, 2020
The framework highlights the important role that Ontario’s nuclear industry plays in providing a secure, long-term supply of Cobalt-60, a medical isotope used, amongst other purposes, to sterilize medical devices and treat cancer. Bruce Power is a key global supplier of medical-grade Cobalt-60, which is processed and distributed by Nordion to customers, such as Xcision, who are using it to revolutionize cancer therapies.